Your browser doesn't support javascript.
loading
SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa.
Smallheer, Joanne M; Alexander, Richard S; Wang, Jianmin; Wang, Shuaige; Nakajima, Suanne; Rossi, Karen A; Smallwood, Angela; Barbera, Frank; Burdick, Debra; Luettgen, Joseph M; Knabb, Robert M; Wexler, Ruth R; Jadhav, Prabhakar K.
Affiliation
  • Smallheer JM; Bristol-Myers Squibb Company, PO Box 5400, Princeton, NJ 08543-5400, USA. joanne.smallheer@bms.com
Bioorg Med Chem Lett ; 14(21): 5263-7, 2004 Nov 01.
Article in En | MEDLINE | ID: mdl-15454208
ABSTRACT
Modifications to the P4 moiety and pyrazole C3 substituent of factor Xa inhibitor SN-429 provided several new compounds, which are 5-10nM inhibitors of factor IXa. An X-ray crystal structure of one example complexed to factor IXa shows that these compounds adopt a similar binding mode to that previously observed with pyrazole inhibitors in the factor Xa active site both with regard to how the inhibitor binds and the position of Tyr99.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Benzimidazoles / Factor IXa / Factor Xa / Factor Xa Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2004 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Benzimidazoles / Factor IXa / Factor Xa / Factor Xa Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2004 Document type: Article Affiliation country: United States